271 related articles for article (PubMed ID: 29915377)
21. Interaction of L-lysine and soluble elastin with the semicarbazide-sensitive amine oxidase in the context of its vascular-adhesion and tissue maturation functions.
Olivieri A; O'Sullivan J; Fortuny LR; Vives IL; Tipton KF
Biochim Biophys Acta; 2010 Apr; 1804(4):941-7. PubMed ID: 20079884
[TBL] [Abstract][Full Text] [Related]
22. Semicarbazide-sensitive amine oxidase and extracellular matrix deposition by smooth-muscle cells.
Langford SD; Trent MB; Boor PJ
Cardiovasc Toxicol; 2002; 2(2):141-50. PubMed ID: 12271157
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammation.
Becchi S; Buson A; Foot J; Jarolimek W; Balleine BW
Br J Pharmacol; 2017 Jul; 174(14):2302-2317. PubMed ID: 28437839
[TBL] [Abstract][Full Text] [Related]
24. Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles.
Gomes FLT; Maranhão RC; Tavares ER; Carvalho PO; Higuchi ML; Mattos FR; Pitta FG; Hatab SA; Kalil-Filho R; Serrano CV
J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):561-569. PubMed ID: 29779420
[TBL] [Abstract][Full Text] [Related]
25. Hydrogen peroxide derived from amine oxidation mediates the interaction between aminosugars and semicarbazide-sensitive amine oxidase.
O'Sullivan J; Davey G; O'Sullivan M; Tipton KF
J Neural Transm (Vienna); 2007; 114(6):751-6. PubMed ID: 17401531
[TBL] [Abstract][Full Text] [Related]
26. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet.
Yu PH; Wang M; Deng YL; Fan H; Shira-Bock L
Diabetologia; 2002 Sep; 45(9):1255-62. PubMed ID: 12242458
[TBL] [Abstract][Full Text] [Related]
27. Vascular adhesion protein-1: Role in human pathology and application as a biomarker.
Pannecoeck R; Serruys D; Benmeridja L; Delanghe JR; van Geel N; Speeckaert R; Speeckaert MM
Crit Rev Clin Lab Sci; 2015; 52(6):284-300. PubMed ID: 26287391
[TBL] [Abstract][Full Text] [Related]
28. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey.
Dunkel P; Balogh B; Meleddu R; Maccioni E; Gyires K; Mátyus P
Expert Opin Ther Pat; 2011 Sep; 21(9):1453-71. PubMed ID: 21675926
[TBL] [Abstract][Full Text] [Related]
29. Leukocyte trafficking-associated vascular adhesion protein 1 is expressed and functionally active in atherosclerotic plaques.
Silvola JM; Virtanen H; Siitonen R; Hellberg S; Liljenbäck H; Metsälä O; Ståhle M; Saanijoki T; Käkelä M; Hakovirta H; Ylä-Herttuala S; Saukko P; Jauhiainen M; Veres TZ; Jalkanen S; Knuuti J; Saraste A; Roivainen A
Sci Rep; 2016 Oct; 6():35089. PubMed ID: 27731409
[TBL] [Abstract][Full Text] [Related]
30. SSAO inhibitors suppress hepatocellular tumor growth in mice.
Li R; Li H; Luo HJ; Lin ZX; Jiang ZW; Luo WH
Cell Immunol; 2013; 283(1-2):61-9. PubMed ID: 23850964
[TBL] [Abstract][Full Text] [Related]
31. Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition.
Katagiri D; Hamasaki Y; Doi K; Negishi K; Sugaya T; Nangaku M; Noiri E
Kidney Int; 2016 Feb; 89(2):374-85. PubMed ID: 26535996
[TBL] [Abstract][Full Text] [Related]
32. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
[TBL] [Abstract][Full Text] [Related]
33. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase.
Langford SD; Trent MB; Balakumaran A; Boor PJ
Toxicol Appl Pharmacol; 1999 Mar; 155(3):237-44. PubMed ID: 10079209
[TBL] [Abstract][Full Text] [Related]
34. Vascular adhesion protein-1 (VAP-1) in vascular inflammatory diseases.
Danielli M; Thomas RC; Quinn LM; Tan BK
Vasa; 2022 Nov; 51(6):341-350. PubMed ID: 36200383
[No Abstract] [Full Text] [Related]
35. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
Solé M; Miñano-Molina AJ; Unzeta M
Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Inhibitor and Substrate Selectivity between Rodent and Human Vascular Adhesion Protein-1.
Kubota R; Reid MJ; Lieu KL; Orme M; Diamond C; Tulberg N; Henry SH
Mediators Inflamm; 2020; 2020():3270513. PubMed ID: 32410850
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
[TBL] [Abstract][Full Text] [Related]
38. Effect of benzylamine and its metabolites on the responses of the isolated perfused mesenteric arterial bed of the rat.
Elliott J; Callingham BA
J Auton Pharmacol; 1991 Oct; 11(5):323-35. PubMed ID: 1748692
[TBL] [Abstract][Full Text] [Related]
39. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
Sun P; Solé M; Unzeta M
Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888
[TBL] [Abstract][Full Text] [Related]
40. Obesity of mice lacking VAP-1/SSAO by Aoc3 gene deletion is reproduced in mice expressing a mutated vascular adhesion protein-1 (VAP-1) devoid of amine oxidase activity.
Jargaud V; Bour S; Tercé F; Collet X; Valet P; Bouloumié A; Guillemot JC; Mauriège P; Jalkanen S; Stolen C; Salmi M; Smith DJ; Carpéné C
J Physiol Biochem; 2021 Feb; 77(1):141-154. PubMed ID: 32712883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
